A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)
Clinical trial NCT06007651 · TERMINATED
Trial details
- NCT number
- NCT06007651
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2025-02-12
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.